A comparative study of phenolic profiles and biological activities of Allium sphaerocephalon L. subsp. sphaerocephalon L. and Allium sphaerocephalon L. subsp. trachypus (Boiss. Et Spruner) K. Richter

Abstract

Allium sphaerocephalon subsp. sphaerocephalon, the common name is known as “Round-Headed Leek”, is an edible plant in different countries. In the present study, bulb, stem and flower extracts of A. sphaerocephalon subsp. sphaerocephalon were compared in terms of phenolic profile and enzyme inhibitory activity, with A. sphaerocephalon subsp. trachypus which is not an edible species. Total phenolic and flavonoid contents of extracts were determined by spectrophotometrically, and bulb parts of both plants were found to be rich in phenolics. Twenty-four selected phenolic compounds were investigated qualitatively and quantitatively in the extracts by LC-MS-MS. Gallic acid (458.4-1246.4 µg/g extract) as phenolic acid and 3-O-methyl quercetin (46.6-136.2 µg/g extract) as a flavonoid were the major compounds in all extracts. In addition, enzyme (acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) and tyrosinase) inhibitory potentials of all samples were performed using a 96-well microplate reader. Flower parts ( IC50, 11.49 µg/mL for AChE) and bulb parts of (IC50, 16.62 µg/mL for BuChE, 65.94 µg/mL for tyrosinase) A. sphaerocephalon subsp. sphaerocephalon were the most potent samples. Also, the results of all analyses were subjected to principal component analysis, to gain insight into the relationship between data of assays.

Keywords

• Allium sphaerocephalon
• phenolics
• cholinesterases
• tyrosinase

References

1. [1] Lattanzio V. Phenolic Compounds: Introduction, In: Ramawat KG, Merillon JM, (eds). Handbook of natural products. Springer-Verlag, Berlin Heidelberg, 2013, p.1544-1573. [CrossRef]
2. [2] Bruneton J, Pharmacognosy, Phytochemistry, Medicinal Plants, second ed. Lavoiser publishing, Paris. 1999.
3. [3] Fraga CG, Galleano M, Verstraeten SV, Oteiza PI. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med. 2010; 31: 435–445. [CrossRef]
4. [4] Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002; 727–730. [CrossRef]
5. [5] Mesulam M, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol. 1994; 36: 722-727. [CrossRef]
6. [6] Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease: A review of progress. J Neurol Neurosurg Psychiatry. 1999; 66: 137–147. [CrossRef]
7. [7] Weinstock M. Selectivity of cholinesterase inhibition: Clinical implications for the treatment of Alzheimer’s disease. CNS Drugs. 1999; 12(4): 307–323. [CrossRef]
8. [8] Zolghadri S, Bahrami A, Hassan Khan MT, Munoz-Munoz J, Garcia-Molina F, Garcia-Canovas F, Saboury AA. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2019; 34(1): 279–309. [CrossRef]

9. [9] Van Kempen LC, Redpath M, Robert C, Spatz A. (2014). Molecular pathology of cutaneous melanoma. Melanoma Manag. 2014; 1(2): 151–164. [CrossRef]
10. [10] Asanuma M, Miyazaki I, Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease. Neurotox Res. 2003; 5(3): 165-176. [CrossRef]
11. [11] Tessari I, Bisaglia M, Valle F, Samorì B, Bergantino E, Mammi S, Bubacco L. The reaction of α-synuclein with tyrosinase: Possible implications for Parkinson disease. J Biol Chem. 2008; 283(24): 16808–16817. [CrossRef]
12. [12] Martinez MV, Whitaker JR. The biochemistry and control of enzymatic browning. Trends Food Sci Tech. 1995; 6: 195– 200. [CrossRef]
13. [13] Emir A, Emir C. Chemical profiles and biological properties of methanol extracts of Allium pallens L. from different localities in Turkey. Arch Biol Sci. 2020; 72(2): 193-201. [CrossRef]
14. [14] Emir C, Emir A. Phytochemical analyses with LC-MS/MS and in vitro enzyme inhibitor activities of an endemic species “Allium stylosum O. Schwarz” (Amaryllidaceae). S Afr J Bot. 2020. [CrossRef]
15. [15] Emir A, Emir C, Yıldırım H. Characterization of phenolic profile by LC-ESI-MS/MS and enzyme inhibitory activities of two wild edible garlic : Allium nigrum L. and Allium subhirsutum L. J Food Biochem. 2020; 44(4): e13165. [CrossRef]
16. [16] Lazarević JS, Ethordević AS, Zlatković BK, Radulović NS, Palić RM. Chemical composition and antioxidant and antimicrobial activities of essential oil of Allium sphaerocephalon L. subsp. sphaerocephalon (Liliaceae) inflorescences. 2011; 91(2): 322-329. [CrossRef]
17. [17] Heimler D, Romani A, Ieri F. Plant polyphenol content, soil fertilization and agricultural management: A review. Eur Food Res Technol. 2017; 243: 1107–1115. [CrossRef]
18. [18] Dziri S, Hassen I, Fatnassi S, Mrabet Y, Casabianca H, Hanchi B, et al. Phenolic constituents, antioxidant and antimicrobial activities of rosy garlic (Allium roseum var. odoratissimum). J Funct Foods. 2012; 4(2): 423–32. [CrossRef]
19. [19] Lachowicz S, Kolniak-Ostek J, Oszmiański J, Wiśniewski R. Comparison of phenolic content and antioxidant capacity of bear garlic (Allium ursinum L.) in different maturity stages. J Food Process Preserv. 2017; 41(1). [CrossRef]
20. [20] Park SY, Je JY, Ahn CB. Phenolic composition and hepatoprotective activities of Allium hookeri against hydrogenperoxide-induced oxidative stress in cultured hepatocytes. J Food Biochem. 2016; 40(3): 284–293. [CrossRef]
21. [21] Aydin C, Mammadov R. Phytochemical analysis, phenolic content, antioxidant, antibacterial, insecticidal and cytotoxic activities of Allium reuterianum Boiss. extracts. Ind J Tradition Knowl. 2019; 18: 290–298. [CrossRef]
22. [22] Katalinić M, Rusak G, Domaćinović Barović J, Šinko G, Jelić D, Antolović R Kovarik Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur J Med Chem. 2010; 45(1): 186–192. [CrossRef]
23. [23] Balkis A, Tran K, Lee YZ, Ng K. Screening flavonoids for inhibition of acetylcholinesterase identified baicalein as the most potent inhibitör. J Agr Sci. 2015; 7: 26–35. [CrossRef]
24. [24] Remya C, Dileep KV, Tintu I, Variyar EJ Sadasivan C. Design of potent inhibitors of acetylcholinesterase using morin as the starting compound. Front Life Sci. 2012; 6 (3-4): 107-117. [CrossRef]
25. [25] Hadacova V, Vackova K, Klozova E, Kutacek M, Pitterova K. Cholinesterase activity in some species of the Allium genus. Biologia plantarum. 1983; 25(3). [CrossRef]
26. [26] Wang HM, Chou YT, Hong ZL, Chen HA, Chang YC, Yang WL, Chang HC, Mai CT, Chen CY. Bioconstituents from stems of Synsepalum dulcificum Daniell (Sapotaceae) inhibit human melanoma proliferation, reduce mushroom tyrosinase activity and have antioxidant properties. J Taiwan Inst Chem Eng. 2011; 42: 204–211. [CrossRef]
27. [27] Boo YC. p-Coumaric acid as an active ingredient in cosmetics: A review focusing on its antimelanogenic effects. Antioxidants. 2019; 8. [CrossRef]
28. [28] Parvez S, Kang M, Chung H and Bae H. Naturally occurring tyrosinase inhibitors: Mechanism and applications in skin health, cosmetics and agriculture industries. Phytother Res. 2007; 21(9): 805-816. [CrossRef]
29. [29] Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Method Enzymol. 1999; 299: 152-178. [CrossRef]
30. [30] Ellman L, Courtney KD, Andres Jr V, Featherstone RM. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7: 88–95. [CrossRef]
31. [31] Masuda T, Yamashita D, Takeda Y, Yonemori S. Screening for tyrosinase inhibitors among extracts of seashore plants and identification of potent inhibitors from Garcinia subelliptica. Biosci Biotechnol Biochem. 2005; 69(1): 197–201. [CrossRef]